Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia: A Prospective 3-month Pilot Study
Sponsor: Hunter College of The City University of New York
A observational or N/A phase clinical study on Schizophrenia and Related Disorders, this trial is completed. The trial is conducted by Hunter College of The City University of New York and has accumulated 7 data snapshots since 2017. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2019 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hunter College of The City University of New York
- University of Catania
- University of Stirling
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .